Alexander Green’s “Next Magnificent Seven” Stock Picks – Become A Millionaire In Six Years?

The Oxford Club's Chief Investment Strategist Alexander Green wants to show us how a small $7,000 portfolio of just seven stocks could make us millionaires in less than six years.

He calls them “The Next Magnificent Seven” and they will dominate the AI era.

We reveal them all for free in this teaser review.

The Teaser

How impactful can identifying a great stock early be?

Our man of the hour, Alexander Green retired from Wall Street at the ripe old age of 43 and joined the world's largest financial “fellowship” (not a cult) with more than 160,000 members – The Oxford Club.

But getting back to our teaser, buying a great stock, such as let's say one of the current “Magnificent Seven,” and the 6th best-performing stock of the last 20 years, Netflix, could have returned more than 1,000% over the last decade alone.

However, this is nothing compared to the #1 performing stock, Apple, which has returned nearly 60,000% over the past two decades, but you get the jist.

Alex believes a select few stocks, seven to be exact, could replicate this performance because of the sudden and dramatic rise of artificial intelligence (AI).

The Biggest Opportunity Since the Internet

The original “Magnificent Seven” stocks or “OG Magnificent Seven” as we'll call them are synonymous with the rise of the internet.

1. Google
2. Microsoft
3. Apple
4. Amazon
5. Nvidia
6. META
7. And Tesla

As Alex explains, just a $1,000 investment in each 20 years ago, or a total of $7,000, would be worth $1.18 million today.

These seven stocks alone have outperformed the overall market 46 to 1 since 2004. No wonder they're called “magnificent.”

As investors, we now know what we have to do…

Identify a handful of stocks that dominate a major new technology like the internet or AI in this case and then invest a few thousand dollars in those stocks.

This is a lot easier said than done, but as a critical first step, Alex has “Five Golden Metrics” we can use to identify “The Next Magnificent Seven stocks.”

The Pitch

All the details on Alex's “Next Magnificent Seven stocks” have been put in a new report called: “The NEXT Magnificent Seven: How These Seven AI Stocks Could Make You a Millionaire.”

The report can be ours with a subscription to the monthly Oxford Communiqué newsletter, which costs $59 upfront, for the first year.

That's 76% off the normal price and includes a full 365-day money-back guarantee, twelve monthly issues containing Alex's favorite investment in the market, two additional special reports, insight emails from The Oxford Club’s global network of associates, which may be spam, and more.

The Five Golden Metrics

Alex admirably admits that he's not perfect at picking stocks.

However, in looking back at stocks that performed exceptionally well for him, almost all of them have had the following five characteristics:

1. It's a leader in cutting-edge technology, just like Apple, Netflix, and Nvidia.
2. It sold breakthrough products used by hundreds of millions of customers around the world.
3. Its technology is protected by patents, trademarks, and brand names.
4. Each one had massive sales growth.
5. And every stock had the potential for dozens of blockbuster launches and announcements that drive the stock higher.

The “Next Magnificent Seven stocks” are no exception and since AI could end up generating more millionaires than any innovation in history, “$7,000 spread out among these picks, could help make us millionaires too.”

Now, claims like these should always be taken with not just a grain, but a whole tablespoon of salt.

So putting money on some AI moonshots is likely to yield an above-average return. Let's find out which ones Alex recommends.

Revealing Alexander Green's “Next Magnificent Seven” Stocks

Alex tells us a bit about each of his seven picks.

Starting with an…

AI CPU Developer That Could Be the Next Trillion-Dollar Company

• This first stock designs, develops, and licenses high-performance central processing units or CPUs – the brain of any AI computing device.
• The company has its advanced CPU technology in over 280 billion chips in “everything from sensors to smartphones to servers.”
• It only IPO’d in 2023.

Alex is talking about UK-based Arm Holdings plc (Nasdaq: ARM).

• Arm Holdings licenses its processor designs to chipmakers, who then manufacture and sell chips based on those designs.
• Since Arm's founding, over 280 billion chips have been manufactured using its architectures.
• Arm IPO'd this past September.
  

The Company Reinventing the Internet with AI

• It owns an array of more than 300 data centers located in cities across the world.
• Approximately 30% of the Fortune 1000 companies are customers.

This is Cloudflare Inc. (NYSE: NET).

• Cloudflare's global network stands at over 300 cities around the world.
• Cloudflare has millions of customers, including approximately 30% of the Fortune 1000 companies.

The Most Exciting and Predictable Way to Invest in AI

• Founded in 1984 and based in the Netherlands, the company is not a household name like Apple, Microsoft, or Nvidia.
• The company specializes in developing, marketing, selling, and servicing advanced semiconductor equipment, specifically photolithography systems.

Alex's third pick is ASML Holding N.V. (Nasdaq: ASML).

• ASML was founded in 1984 as a Joint Venture between ASMI and Philips.
• The company specializes in the development and manufacturing of photolithography machines, which are used to produce semiconductor chips.

The Biotech Using AI to Cure Disease at the Cellular Level

• The fourth Next Magnificent Seven stock uses AI to discover and fix problems at the cellular level.
• It has 1750 patents protecting its technology from competitors.
• The company’s products are used by all of the top 100 global research institutions.

Alex is talking about 10x Genomics Inc. (Nasdaq: TXG) here.

• 10x has more than 1,750 patents and patent applications to its name.
• Among its customer base are researchers across the world, including all of the top 100 global research institutions (Harvard, MIT, Stanford, Columbia, Yale, and others).

AI Robots Revolutionizing Manufacturing

• A developer of AI software and robotics for supply chains in the United States.
• Its robots can navigate giant distribution centers at speeds up to 20 mph, stocking and retrieving goods in a fraction of the time compared to old technology.
• The company packages, stocks, and ships out goods for some of the biggest retailers in the world.

The pick here is Symbotic Inc. (Nasdaq: SYM).

• Symbotic builds and operates automated warehouse systems using artificial intelligence.
• The company has deals in place with the likes of Walmart, Target, and Albertsons.

The Company Protecting Us from the Dangers of AI

• This company has built an AI technology that instantly authenticates and verifies authorized users.
• It provides cybersecurity for American Express, BP, Deutsche Bank, UBS, Suncor, Metlife, and even NASA.

Some online have already revealed this pick, it is CyberArk Software Ltd. (NASDAQ: CYBR).

• CyberArk specializes in identity management for corporate clients.
• It keeps its client list under tight wraps, but I was able to find UBS and others listed as customers on a third-party site.

Alex's #1 Stock Going Into This Year

• The company operates in a new technology that was only invented just over 10 years ago called “gene-editing.”
• It is the first company ever to win full approval for a gene-editing drug and it expects to have 20 different treatments available in the next five years.

The final pick is Crispr Therapeutics AG (Nasdaq: CRSP).

• The CRISPR-Cas9 system as a gene-editing tool was first discovered in 2012 and the co-founder's CRISPR Therapeutics along with its partner Vertex Pharmaceuticals, are the first to win FDA approval for a gene-editing drug.

Become A Millionaire in the Next Six Years?

At the outset of the teaser, Alex mentioned that “just $1,000 in each of his “Next Magnificent Seven” stock picks could help us become millionaires in the next six years.”

We don't have a crystal ball, but here is how each pick stacks up today:

Arm Holdings: Huge 121% run-up over the past year, now trading at nearly 400x earnings. Waiting for a better entry point is prudent.

Cloudflare: Lots of dilution due to employee stock option plan and no durable competitive advantage over other cybersecurity providers.

ASML Holding: As close to a monopoly as one will find in the market, its recent pullback means now is an ideal time to buy.

10x Genomics: Growing revenue by about 20% annually, but operating losses are growing by even more. Not a good sign for a software business.

Symbotic: The company is expected to break even next year, which would make this an opportune time to pick up some shares.

CyberArk Software: It is an entrenched cybersecurity incumbent, but it's in the same boat as Cloudflare over the long term.

Crispr Therapeutics: The stock hasn't done much over the past few years, but I can see this changing now that it is going to market with treatments.

A real mixed bag here, with some no-brainers and a couple of questionable calls.

I see ARM (price aside), ASML, Symbotic, and Crispr as the most likely candidates to be included in a “Next Magnificent Seven.”

Quick Recap & Conclusion

• The Oxford Club's Chief Investment Strategist Alexander Green wants to show us how a small $7,000 portfolio of just seven stocks could make us millionaires in less than six years.
• He calls them “The Next Magnificent Seven” and they will dominate the AI era because they all possess “Five Golden Metrics.”
• All the details on Alex's “Next Magnificent Seven stocks” have been included in a new report called: “The NEXT Magnificent Seven: How These Seven AI Stocks Could Make You a Millionaire.” The report can be ours with a subscription to the monthly Oxford Communiqué newsletter, which costs $59 upfront, for the first year.
• We were able to reveal all of Alex's picks right here for free and they are Arm Holdings plc (Nasdaq: ARM), Cloudflare Inc. (NYSE: NET), ASML Holding N.V. (Nasdaq: ASML), 10x Genomics Inc. (Nasdaq: TXG), Symbotic Inc. (Nasdaq: SYM), CyberArk Software Ltd. (NASDAQ: CYBR), and Crispr Therapeutics AG (Nasdaq: CRSP).
• Based on what we know today, ARM (price aside), ASML, Symbotic, and Crispr are the four businesses that stand out among Alex's seven picks.

Which “Next Magnificent Seven” do you believe has the most upside potential? Let us know in the comments.